| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |